As a biotech firm, you need to make sure your accounting tracks the various aspects of your life sciences organization. Failure can inhibit your ability to manage projects and drive financial success. Lescault and Walderman has the specialized experience and expertise you need to get more from your accounting data.
For those Biotech firms set up as small-cap publicly-traded corporations, we are well-versed in the reporting and financial management necessary to satisfy the complex regulatory requirements. That’s why our solutions provide on-demand dashboard reporting.
If you use multiple entities for legal structure purposes, your accounting solution needs to have consolidation capabilities that are only offered by single accounting/ERP systems. Our partnership with Sage Intacct allows us to build enterprise-level financial data dashboards so you can quickly and effectively access individual project reports across multiple entities and locations.
We also provide clear and actionable budgeting and forecasting. When you have realistic budgets, you can establish accountability for each of your departments. This fiscal accountability can be tied directly to specific projects to better manage Research and Development and Clinical Trials. Accurate forecasts are also essential. When you work from a reliable forecast, you will experience fewer surprises and setbacks.
Unfortunately, accounting systems typically fail to match the unique applications of wide-ranging Biotech company profiles. When you work with Lescault and Walderman, you’ll implement a custom accounting for biotech solution that fits your budget and technical requirements.